Efficacy and Safety of HER2-Targeted Agents for Breast Cancer with HER2-Overexpression: A Network Meta-Analysis.

<h4>Background</h4>Clinical trials of human epidermal growth factor receptor 2 (HER2)-targeted agents added to standard treatment have been efficacious for HER2-positive (HER2+) advanced breast cancer. To our knowledge, no meta-analysis has evaluated HER2-targeted therapy including trast...

Full description

Saved in:
Bibliographic Details
Main Authors: Qiuyan Yu, Zhenli Zhu, Yan Liu, Jun Zhang, Ke Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0127404&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!